Jillian B. Thomsen

Jillian B. Thomsen

Former Chief Financial Officer and Chief Accounting OfficeratNektar Therapeutics· In proxies 2022–2023

Pay in FY2022Nektar Therapeutics stock -83.3% the same year

Jillian B. Thomsen was paid $4.6M in FY2022 (Dec). Nektar Therapeutics stock fell 83.3% that year.

Pay$100 in the stock at the end of FY21 → $17
Pay is from the Summary Compensation Table of each Nektar Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Nektar TherapeuticsPublic company · 4 yr
    • Former Chief Financial Officer and Chief Accounting Officer2022 – Present · 4 yrStock in role -83%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?